Efter første indgivelse anbefales det, at patienten holdes under opsyn af en medicinsk kyndig person i 30 minutter, for at sikre, at der ikke opstår en allergisk/ pseudoallergisk reaktion på injektionen.
Following the first administration, it is advised that the patient be kept under medical supervision for 30 minutes to ensure there is no allergic/ pseudo-allergic reaction reaction to the injection.